Is Africa lost? (Q44183829)

30 November 2017

Is Africa lost? (English)

1 reference

30 November 2017

J. L. Stanford

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678812

27 October 2022

J. M. Grange

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678812

27 October 2022

A. Pozniak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678812

27 October 2022

language of work or name

English

0 references

publication date

1 August 1991

1 reference

30 November 2017

31 August 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1678812

full work available at URL

27 October 2022

number of pages

2

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0140673691911139?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91113-9

https://api.elsevier.com/content/article/PII:0140673691911139?httpAccept=text/plain

27 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91113-9

27 October 2022

1 reference

30 November 2017

338

1 reference

30 November 2017

557-558

1 reference

30 November 2017

8766

1 reference

Immunotherapy with Mycobacterium vaccae as an adjunct to chemotherapy in the treatment of pulmonary tuberculosis

30 November 2017

2

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91113-9

Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council

27 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91113-9

Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in south India.

27 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91113-9

Improved immunotherapy for pulmonary tuberculosis with Mycobacterium vaccae

27 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91113-9

The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG

27 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91113-9

Cytokines and the Koch phenomenon

27 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91113-9

Augmentation of in-vitro HIV replication in peripheral blood mononuclear cells of AIDS and ARC patients by tumour necrosis factor

27 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91113-9

27 October 2022

Identifiers

1 reference

30 November 2017

1 reference